News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Pawel Kalinski: The use of TAAs as ubiquitous targets for adoptive T cell therapies in solid tumors
Photo taken from Pawel Kalinski/LinkedIn
Sep 3, 2024, 12:16

Pawel Kalinski: The use of TAAs as ubiquitous targets for adoptive T cell therapies in solid tumors

Pawel Kalinski, Senior Vice President for Team Science at Roswell Park Comprehensive Cancer Center, shared on LinkedIn:

“Contratulatuons to Dr. Dong for his impressive PhD thesis and for this critical contribution to our understanding of how cytotoxic lymphocytes (CTLs) can selectively recognize low levels of unmutated tumor-associated antigens (TAAs) on cancer cells, but not the same antigens expressed by healthy tissues

Best wishes for his postdoctoral research at our lab in developing a new class of T cell therapies, using dual recognition by TCR (or CAR) and NK receptors (NKRs) to allow the use of TAAs as ubiquitous targets for adoptive T cell therapies (ACT) in solid tumors.

‘NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs‘

Authors: Bowen Dong, Natasa Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy M Bonura, Cindy Sander, Henry Withers, Mark D Long, Colin Chavel, Scott H Olejniczak, Hans Minderman, John M Kirkwood, Robert P Edwards, Walter J Storkus, Pedro Romero, Pawel Kalinski. ”

Pawel Kalinski: The use of TAAs as ubiquitous targets for adoptive T cell therapies in solid tumors

Source: Pawel Kalinski/LinkedIn

Bowen Dong cancer Cindy M Bonura Cindy Sander Colin Chavel cytotoxic lymphocytes Hans Minderman Henry Withers John M. Kirkwood Junko Matsuzaki Mark D Long Natasa Obermajer NK receptors OncoDaily Oncology Pawel Kalinski Pedro Romero Robert P Edwards Scott H Olejniczak Takemasa Tsuji Walter J Storkus
Special Coverage
Positive
Nov 14, 2024, 07:38
Clarissa Baldotto Elected President of the SBOC for 2026: Marking a New Era of Leadership
Opinion
Nov 14, 2024, 00:24
Jennifer Buell: Thrilled to share MiNK Therapeutics' groundbreaking work at SITC 2024
Opinion
Nov 14, 2024, 00:19
Leadership Opportunity: Young SIOP Network Chair
Opinion
Nov 14, 2024, 00:18
Partha Basu: The JNCI Monograph dedicated to a single dose of HPV vaccine is out
Blog
Nov 14, 2024, 00:09
Zainab Shinkafi-Bagudu: Potential partnerships to advance cancer awareness and strengthen health policies across Nigeria
Blog
Nov 14, 2024, 00:05
Stephen V Liu: Federico Cappuzzo on perioperative immunotherapy at VIII Thoracic Oncology Conference
Blog
Nov 14, 2024, 00:02
The ACS-Jiler Professors and Fellows Conference - American Cancer Society
Blog
Nov 13, 2024, 23:59
Amanda Balakirsky: An exciting opportunity to meet leaders in the field of psycho-oncology
Blog
Nov 13, 2024, 23:57
The Latest ESO Visiting Professor Meeting in Pristina with Alina Sturdza
Opinion
Nov 13, 2024, 23:54
The Lung-MAP 3.0 revision
Opinion
Nov 13, 2024, 23:52
Growing the pipeline of talented Black researchers in cancer - President's Cancer Panel
Opinion
Nov 13, 2024, 23:48
Why pursue a career in psycho-oncology? New speaker: Linda Carlson - IPOS